have to think in an area with basically no safe treatment...

have to think in an area with basically no safe treatment options, this is very exciting for parents. 93% of patients had symptom improvement is quite incredible from a humble little plant. What is most exciting is this is just data from 28 days and the chairman stated "The fact that the results are based on a 28 day trial period with further significant results from patients who have remained on the treatment"... Is he trying to tell us the the efficacy is improving over time.. I think so.

Also the obvious one is that this opens up interest in all other neurological disorders - a long pipeline of opportunities across different indications.

This should make some good press over the weekend, and I expect Monday will see more volume and highs off the back of that..

GLTAH.